- Received November 8, 2016.
- Revision received February 17, 2017.
- Accepted February 21, 2017.
- Published first February 27, 2017.
Copyright & Usage
Copyright ©2017, American Association for Cancer Research.
- Johann de Bono1,*,
- Ramesh K. Ramanathan2,
- Lida Mina3,
- Rashmi Chugh4,
- John Glaspy5,
- Saeed Rafii1,
- Stan Kaye1,
- Jasgit Sachdev2,
- John Heymach6,
- David C. Smith4,
- Joshua W. Henshaw7,
- Ashleigh Herriott8,
- Miranda Patterson8,
- Nicola J. Curtin8,
- Lauren Averett Byers6 and
- Zev A. Wainberg5
- 1Drug Development Unit, Royal Marsden Hospital
- 2Clinical Trials Program, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen
- 3Simon Cancer Center, Indiana University
- 4Division of Hematology/Oncology, University of Michigan
- 5Division of Hematology/Oncology, David Geffen School of Medicine at UCLA
- 6Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center
- 7Pharmacokinetics/Pharmacodynamics, BioMarin Pharmaceutical, Inc.
- 8Northern Institute for Cancer Research, Newcastle University
- ↵* Corresponding Author:
Johann de Bono, Drug Development Unit, Royal Marsden Hospital, 15 Cotswold Rd, Sutton, Surrey, SM2 5NG, United Kingdom. E-mail: